Product correctly added to cart.

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
View 3D

Indagoo logo

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone

CAS: 104987-11-3

Ref. AN-AG0039L0

1g
Discontinued
5g
Discontinued
50mg
Discontinued
100mg
Discontinued
250mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
Synonyms:
  • [u'Anhydrous Tacrolimus', u'Anhydrous, Tacrolimus', u'FK 506', u'FK-506', u'FK506', u'FR 900506', u'FR-900506', u'FR900506', u'Prograf', u'Prograft', u'Tacrolimus', u'Tacrolimus Anhydrous', u'Tacrolimus, Anhydrous', u'tacrolimus', u'104987-11-3', u'Prograf', u'Protopic', u'Fujimycin', u'Tsukubaenolide', u'FK506', u'Tacrolimus anhydrous', u'Modigraf', u'Protopy', u'LCP-Tacro', u'Fk-506', u'FK 506', u'Anhydrous Tacrolimus', u'tacrolimus (fk506)', u'FR-900506', u'Advagraf', u'8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN', u'UNII-Y5L2157C4J', u'K506', u'Astagraf XL', u'(-)-FK 506', u'Prograf (TN)', u'FR900506', u'Tacarolimus', u'CHEMBL269732', u'CHEBI:61049', u'FR 900506', u'Y5L2157C4J', u'MFCD11045918', u'FK5', u'109581-93-3', u'Tacrolimus (anhydrous)', u'NCGC00163470-03', u'Prograft', u'Tacrolimus [USAN]', u'CCRIS 7124', u'Avagraf', u'Envarsus', u'Graceptor', u'L 679934', u'Envarsus XR', u'Tacrolimus (INN)', u'FK-506 (Tacrolimus)', u'Tacrolimus, anhydrous', u'SR-05000001879', u'Tacrolimus [USAN:INN]', u'Hecoria', u'Talymus', u'HSDB 8195', u'FK-506/Tacrolimus', u'PubChem18875', u'AC1L9IBU', u'SCHEMBL3088', u'DSSTox_CID_26354', u'DSSTox_RID_81557', u'DSSTox_GSID_46354', u'BSPBio_001279', u'CHEMBL66247', u'L-679934', u'GTPL6784', u'DTXSID5046354', u'CHEBI:93221', u'HMS503O21', u'QJJXYPPXXYFBGM-LFZNUXCKSA-N', u'C44H69NO12', u'HMS1792O21', u'HMS1990O21', u'HMS2093M19', u'HMS3403O21', u'Pharmakon1600-01503968', u'15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-(2-(4-hydroxy-3-methoxycyclohexyl)-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-, (3S-(3R*(E(1S*,3S*,4S*)),4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*))-', u'EX-A1677', u'Tox21_112056', u'ABP000474', u'BDBM50030448', u'BDBM50079777', u'LMPK04000003', u'NSC758659', u's5003', u'AKOS005145901', u'ZINC169289411', u'AC-1182', u'AM81227', u'AT-2441', u'CS-1507', u'DB00864', u'NSC-758659', u'IDI1_001040', u'NCGC00163470-01', u'NCGC00163470-02', u'NCGC00163470-04', u'NCGC00163470-05', u'NCGC00163470-06', u'NCGC00163470-07', u'BC205151', u'HY-13756', u'SC-13591', u'Fujimycin|||FK-506|||FR-900506', u'SBI-0052894.P002', u'AB0012538', u'CAS-104987-11-3', u'FT-0082660', u'M2258', u'C01375', u'D08556', u'EN300-221601', u'W-1246', u'AB01209746-01', u'AB01209746_03', u'581T933', u'Q-201775', u'SR-05000001879-1', u'SR-05000001879-2', u'SR-05000001879-5', u'BRD-K35452788-001-02-1', u'BRD-K69608737-001-03-7', u'BRD-K69608737-001-10-2', u'[(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-', u'15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,', u'(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone']
Brand:
Indagoo
Long term storage:
Notes:

Chemical properties

Molecular weight:
804.0182
Formula:
C44H69NO12
Purity:
98%
Color/Form:
Solid
InChI:
InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1
InChI key:
QJJXYPPXXYFBGM-LFZNUXCKSA-N
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: AN-AG0039L0 (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".